Anchor Capital Advisors LLC grew its position in shares of Medtronic plc. (NYSE:MDT) by 2.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 275,625 shares of the medical technology company’s stock after buying an additional 6,059 shares during the quarter. Anchor Capital Advisors LLC’s holdings in Medtronic were worth $22,257,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of the business. Janus Henderson Group PLC bought a new stake in shares of Medtronic during the third quarter valued at approximately $579,952,000. Lazard Asset Management LLC grew its stake in shares of Medtronic by 43.8% during the second quarter. Lazard Asset Management LLC now owns 19,669,866 shares of the medical technology company’s stock valued at $1,745,699,000 after purchasing an additional 5,991,094 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in Medtronic by 135.5% in the second quarter. Alliancebernstein L.P. now owns 6,070,160 shares of the medical technology company’s stock valued at $538,727,000 after buying an additional 3,493,058 shares during the period. BlackRock Inc. lifted its holdings in Medtronic by 2.8% in the second quarter. BlackRock Inc. now owns 89,512,229 shares of the medical technology company’s stock valued at $7,944,210,000 after buying an additional 2,476,853 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in Medtronic by 2.4% in the second quarter. Vanguard Group Inc. now owns 104,776,036 shares of the medical technology company’s stock valued at $9,298,872,000 after buying an additional 2,454,380 shares during the period. 81.97% of the stock is currently owned by hedge funds and other institutional investors.
In related news, EVP Bryan C. Hanson sold 16,000 shares of the firm’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $82.82, for a total transaction of $1,325,120.00. Following the sale, the executive vice president now directly owns 88,818 shares in the company, valued at $7,355,906.76. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Richard Kuntz sold 78,526 shares of the firm’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $86.21, for a total transaction of $6,769,726.46. Following the sale, the vice president now owns 149,761 shares in the company, valued at $12,910,895.81. The disclosure for this sale can be found here. Over the last quarter, insiders sold 136,684 shares of company stock worth $11,582,596. Company insiders own 0.31% of the company’s stock.
Shares of Medtronic plc. (NYSE MDT) opened at $79.48 on Friday. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50. The firm has a market cap of $107,580.00, a price-to-earnings ratio of 21.84, a price-to-earnings-growth ratio of 2.16 and a beta of 0.93. Medtronic plc. has a twelve month low of $75.71 and a twelve month high of $89.72.
Medtronic (NYSE:MDT) last posted its earnings results on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.99 by $0.08. The company had revenue of $7.05 billion for the quarter, compared to analyst estimates of $7.05 billion. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The business’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period last year, the business posted $1.12 earnings per share. sell-side analysts anticipate that Medtronic plc. will post 4.76 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, January 19th. Shareholders of record on Friday, December 29th were issued a $0.46 dividend. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $1.84 annualized dividend and a yield of 2.32%. Medtronic’s dividend payout ratio (DPR) is presently 50.55%.
Several brokerages recently weighed in on MDT. Morgan Stanley increased their price objective on shares of Medtronic from $91.00 to $95.00 and gave the company an “equal weight” rating in a report on Monday, February 5th. Oppenheimer set a $94.00 price objective on shares of Medtronic and gave the company a “buy” rating in a report on Friday, January 19th. Cowen restated a “buy” rating and issued a $95.00 price objective on shares of Medtronic in a report on Friday, November 3rd. Jefferies Group restated a “buy” rating and issued a $99.00 price objective on shares of Medtronic in a report on Thursday, November 23rd. Finally, Stifel Nicolaus increased their price objective on shares of Medtronic from $83.00 to $85.00 and gave the company a “hold” rating in a report on Wednesday, November 22nd. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $90.10.
WARNING: “Medtronic plc. (MDT) Shares Bought by Anchor Capital Advisors LLC” was first published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://transcriptdaily.com/2018/02/11/medtronic-plc-mdt-shares-bought-by-anchor-capital-advisors-llc.html.
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.